Cancer center's physician-in-chief leads PurpleStride

UC Davis

Take steps to help find a cure for the third most deadly cancer in the U.S. by participating in PurpleStride Sacramento. The fundraiser to fight pancreatic cancer is set for Saturday, April 29, 9:00 a.m., at William Land Park.

Dark haired man in doctor scrubs smiling
UC Davis Comprehensive Cancer Center physician-in-chief is captain of the cancer center's PurpleStride team.

Hosted by the Pancreatic Cancer Action Network (PanCAN), PurpleStride USA raises money to advocate for pancreatic cancer research, conduct community outreach and provide patient and caregiver support.

UC Davis Comprehensive Cancer Center is participating, with a team goal of raising $2,000. The team captain is Richard Bold, physician-in-chief of the cancer center. He encourages anyone touched by pancreatic cancer or interested in helping fight the devastating disease to visit the cancer center's PurpleStride team site to contribute or join the team for the in-person event.

American Cancer Society's Cancer Facts & Figures 2023 reports that the five-year survival rate for pancreatic cancer is now 12%, an increase of one percentage point from last year. This is the first time since 2017 that the survival rate has gone up two years in a row.

"This is a promising upward trend that points to continued progress in the fight against this tough disease, but there is much more work to be done to fight this cancer that's so difficult to treat," Bold said.

Bold said UC Davis Comprehensive Cancer Center is determined to double down on pancreatic cancer, with research underway to uncover risk factors and treat patients through early-stage clinical trials.

"We want to dramatically change the outcomes of pancreatic cancer, but we can't do it alone," Bold said. "PurpleStride is the largest pancreatic cancer fundraiser of its kind. This is a great opportunity to join our local community to fight this rare, but deadly cancer."

PanCAN provides a range of services for patients with dedicated volunteers and a Patient Services team. The nonprofit also supports research and advocacy work with a bold goal of driving the five-year survival rate to 20% by 2030.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.